Evidence map›Paper›PMID 23298205›Full record

ReviewAnnual review of immunology2013

Pathways of antigen processing.

Janice S Blum, Pamela A Wearsch, Peter Cresswell

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 885 papers.

0numbers the graph read from it
0cells of the map it votes in
885citing papers in PubMed
40.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

885 citing papers in PubMed, 1,491 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Quantitative nanoscale imaging shows peptide-MHC I complexes are monomeric and spatially regulated in human dendritic cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Technical review of artificial intelligence in TCR-T therapy.Journal of the National Cancer Center · 2026
    Review

825 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Janice S BlumDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. jblum@iupui.edu
Pamela A Wearsch
Peter Cresswell
Case Western Reserve University · USIndiana University – Purdue University Indianapolis · USYale University · US

Funding

Poxvirus Modulation of Immune ResponsesP01AI056097 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BLUM, JANICE S · 2003 to 2010
$9.9M
Transgenic Mouse CoreP01AI084853 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI GREENSPAN, DANIEL S · 2010 to 2014
$7.7M
Molecular Aspects of Human CD1d FunctionsR01AI059167 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2004 to 2019
$5.6M
Quality Control of MHC Class I Restricted Antigen ProcessingR01AI097206 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2012 to 2020
$4.1M
Type 1 Diabetes TrialNet at Indiana University Clinical CenterU01DK085505 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DIMEGLIO, LINDA A · 2009 to 2013
$3.0M
M. tuberculosis lipoprotein-TLR2 interactionsR01AI069085 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2007 to 2011
$1.9M
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGYR01AI079065 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI BLUM, JANICE S · 2010 to 2014
$1.8M
MHC Class II-restricted Cytoplasmic Antigen PresentationR56AI049589 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BLUM, JANICE S · 2007 to 2007
$300k
Howard Hughes Medical InstituteNIAID NIH HHS P01 AI056097NIAID NIH HHS P01 AI084853NIAID NIH HHS P01AI084853NIAID NIH HHS R01 AI059167NIAID NIH HHS R01AI059167NIAID NIH HHS R01 AI069085NIAID NIH HHS R01AI069085NIAID NIH HHS R01 AI079065NIAID NIH HHS R01AI079065NIAID NIH HHS R01 AI097206NIAID NIH HHS R01AI097206NIAID NIH HHS R56 AI049589NIDDK NIH HHS U01 DK085505NIDDK NIH HHS U01DK085505
6 · The paper itself

Abstract

T cell recognition of antigen-presenting cells depends on their expression of a spectrum of peptides bound to major histocompatibility complex class I (MHC-I) and class II (MHC-II) molecules. Conversion of antigens from pathogens or transformed cells into MHC-I- and MHC-II-bound peptides is critical for mounting protective T cell responses, and similar processing of self proteins is necessary to establish and maintain tolerance. Cells use a variety of mechanisms to acquire protein antigens, from translation in the cytosol to variations on the theme of endocytosis, and to degrade them once acquired. In this review, we highlight the aspects of MHC-I and MHC-II biosynthesis and assembly that have evolved to intersect these pathways and sample the peptides that are produced.

Indexed as

AnimalsAntigen PresentationHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansImmune ToleranceMembrane GlycoproteinsPeptidesProtein BindingSignal TransductionT-Lymphocyte SubsetsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMembrane GlycoproteinsPeptides

Identifiers

PMID23298205
PMCPMC4026165
OpenAlexW2102237050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.